Search results
Results from the WOW.Com Content Network
Acrophobia, also known as hypsophobia, is an extreme or irrational fear or phobia of heights, especially when one is not particularly high up. It belongs to a category of specific phobias, called space and motion discomfort, that share similar causes and options for treatment.
The English suffixes -phobia, -phobic, -phobe (from Greek φόβος phobos, "fear") occur in technical usage in psychiatry to construct words that describe irrational, abnormal, unwarranted, persistent, or disabling fear as a mental disorder (e.g. agoraphobia), in chemistry to describe chemical aversions (e.g. hydrophobic), in biology to describe organisms that dislike certain conditions (e.g ...
Medication phobia can be triggered by unpleasant adverse reactions to medications which are sometimes prescribed inappropriately or at excessive doses. Lack of awareness of the patient's predisposition to adverse effects (e.g. anxious patients and the elderly) and failure to attribute the adverse effects to the drug serves to compound the phobia.
Algophobia or algiophobia is a phobia of pain - an abnormal and persistent fear of pain that is far more powerful than that of a normal person. [1] [2] It can be treated with behavioral therapy and anti-anxiety medication. The term comes from the Greek: ἄλγος, álgos, "pain" and φόβος, phóbos, "fear".
Although fears are common and normal, a phobia is an extreme type of fear where great lengths are taken to avoid being exposed to the particular danger. Phobias are considered the most common psychiatric disorder, affecting about 10% of the population in the US, [ 3 ] according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth ...
Kinesiophobia can be measured by doing multiple tests for fear of falling, fear of pain, fear of movement-related pain, etc. There have been multiple studies for some of these fears and the best instruments that were used. The most common instruments that were used were TSK, PASS, and SAFFE. [11]
An article in the May issue of the New England Journal of Medicine called for wider U.S. use of medication-assisted therapies for addicts, commonly referred to as MATs. It was written by Dr. Nora Volkow, director of the U.S. National Institute on Drug Abuse — which helped research Suboxone before it earned FDA approval in 2002 — along with ...
After five sessions, exposure treatment has been shown to provide benefit to the patient. However, it is still recommended treatment continue beyond the initial five sessions. [83] Virtual reality therapy (VRT) has shown to be effective for a fear of heights. [84] It has also been shown to help with the treatment of a variety of anxiety ...